おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Neuromed Pharmaceuticals
company
About
Neuromed Pharmaceuticals, Ltd., a biopharmaceutical company, develops, produces, markets, and sells pain therapies.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $32M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 1998
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Neuromed Pharmaceuticals is focused on the development, production, and marketing of pain therapies in Canada and the United States.Neuromed Pharmaceuticals was acquired by Zalicus in December 2009.Neuromed Pharmaceuticals was founded in 1998 and is based in Vancouver, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$57M
Neuromed Pharmaceuticals has raised a total of
$57M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2006 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2006 | Series D | $25M | 1 | — | — | Detail |
| Nov 4, 2003 | Series C | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Neuromed Pharmaceuticals is funded by 1 investors.
Cogene Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
